Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03644472 · ClinicalTrials.gov registry record · Phase 2

Postmenopausal Women and Their Endothelium

A Phase 2 study of Postmenopausal Women, sponsored by Penn State University.

Completed
Registry status
Phase 2
Development phase
37
Enrollment target
1
Study location

NCT03644472 is a Phase 2 study of Postmenopausal Women that has completed, run by Penn State University. The registered enrollment target is 37 participants, below the 91-participant average among 4 other Postmenopausal Women trials with a reported enrollment target (59% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03644472, a Phase 2 study of Postmenopausal Women, has completed, sponsored by Penn State University.

COMPLETED
Registry status
Phase 2
Development phase
37 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to test the effects of a one time dose and 7-days of inorganic nitrate (supplied in the form of beetroot juice) on blood vessel function and resting blood pressure in healthy, postmenopausal women. Participants will drink beetroot juice and a placebo juice on separate visits where blood pressure and blood vessel function will be measured.

Conditions Studied

Interventions

  • DRUG nitrate rich beetroot juice
  • DRUG nitrate depleted beetroot juice

Study Locations (1)

Pennsylvania

  • Penn State University - University Park

Trial Details

FieldValue
Enrollment Target 37 participants
Start Date 2018-11-07
Est. Completion 2023-02-20
Phase Phase 2

Sponsor

Penn State University

219 total trials

What the Registry Record Tells You About NCT03644472

The ClinicalTrials.gov registry entry for NCT03644472 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 37 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 91-participant average among 4 other Postmenopausal Women trials with a reported enrollment target (59% lower). The listed sponsor is Penn State University, which has 219 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Postmenopausal Women appearing as the primary indexed condition, and to 2 interventions - of which nitrate rich beetroot juice is the first listed.

NCT03644472 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT03644472 about?

NCT03644472 is a clinical study titled "Postmenopausal Women and Their Endothelium". The purpose of this study is to test the effects of a one time dose and 7-days of inorganic nitrate (supplied in the form of beetroot juice) on blood vessel function and resting blood pressure in healthy, postmenopausal women. Participants will drink beetroot juice and a placebo juice on separate vi...

What is the current status of trial NCT03644472?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 37 participants. The study started on 2018-11-07. Estimated completion is 2023-02-20.

What conditions does trial NCT03644472 study?

This clinical trial studies the following conditions: Postmenopausal Women.

What interventions are being tested in trial NCT03644472?

The interventions under investigation include: nitrate rich beetroot juice (DRUG), nitrate depleted beetroot juice (DRUG).

Who is sponsoring clinical trial NCT03644472?

This trial is sponsored by Penn State University, which has 219 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03644472 being conducted?

This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Postmenopausal Women

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.